MedTrace Logo

The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood

NCT02763514 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 337

Last updated 2019-01-24

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of EPA- and DHA-enriched omega-3 polyunsaturated fatty acid dietary supplements on cognitive function (episodic memory, attention, working memory, executive function), subjective mood, alertness and mental fatigue after 26 weeks daily supplementation.

Conditions

  • Cognitive Function

Interventions

DIETARY_SUPPLEMENT

3 g PronovaPure 150:500 EE EU

DIETARY_SUPPLEMENT

3 g PronovaPure 500:200 EE EU

DIETARY_SUPPLEMENT

3 g Placebo

Sponsors & Collaborators

  • Pronova BioPharma

    collaborator INDUSTRY

  • Northumbria University

    lead OTHER

Principal Investigators

  • Philippa Jackson, PhD · Northumbria University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02763514 on ClinicalTrials.gov